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ABSTRACT
Exonic splicing enhancers (ESEs) are pre-mRNA cis-
acting elements required for splice-site recognition.
Wepreviouslydevelopedaweb-basedprogramcalled
ESEfinder that scores any sequence for the presence
of ESE motifs recognized by the human SR proteins
SF2/ASF, SRp40, SRp55 and SC35 (http://rulai.cshl.
edu/tools/ESE/). Using ESEfinder, we have under-
taken a large-scale analysis of ESE motif distribution
in human protein-coding genes. Significantly higher
frequencies of ESE motifs were observed in consti-
tutive internal protein-coding exons, compared with
both their flanking intronic regions and with pseudo
exons.StatisticalanalysisofESEmotiffrequencydis-
tributions revealed a complex relationship between
splice-site strength and increased or decreased fre-
quenciesofparticularSRproteinmotifs.Comparison
of constitutively and alternatively spliced exons
demonstrated slightly weaker splice-site scores, as
well as significantly fewer ESE motifs, in the alterna-
tively spliced group. Our results underline the impor-
tance of ESE-mediated SR protein function in the
processofexon definition,inthe context of bothcon-
stitutive splicing and regulated alternative splicing.
INTRODUCTION
Processing of pre-mRNA is a fundamental aspect of gene
regulation. Most eukaryotic genes comprise multiple rela-
tively short exons that are separated by much longer introns.
The basic mechanism of splicing involves exon recognition
via the 50 and 30 splice sites and branch site at or near the intron
ends, and the precise removal of intronic sequences and liga-
tion of exons, generating mature mRNA (1). However, accu-
rate exon deﬁnition by the spliceosome is complicated by the
presence of numerous intronic pseudo exons ﬂanked by
sequences that conform to the splice-site consensus motifs
at least as well as those utilized by many true exons (2).
The additional information required for exon deﬁnition is con-
tained at least partly in cis-acting regulatory enhancer and
silencer sequences (3).
Exonic splicing enhancers (ESEs) participate in both alter-
native and constitutive splicing, and many of them act as
binding sites for members of the SR protein family (4,5).
The SR proteins are a family of related proteins that share
a conserved domain structure. They have one or two copies of
an RNA-recognition motif (RRM) followed by a C-terminal
domain that is highly enriched in arginine/serine dipeptides
(RS domain) (6). The RRMs mediate substrate recognition via
sequence-speciﬁc RNA binding, whereas the RS domain is
thought to be involved mainly in protein–protein interactions,
but apparently also in protein–RNA interactions (7,8). Exon
deﬁnition may occur through ESE-bound SR proteins recruit-
ing components of the splicing machinery through their RS
domains (9,10), and/or by antagonizing the action of nearby
splicing silencer elements (11).
It has been estimated that at least 15% of point mutations
that give rise to human genetic diseases cause RNA splicing
defects (12). These mutations exert their effects upon the
standard consensus intronic splice sites, and normally result
in exon skipping, or less commonly in the creation of an
ectopic splice site or activation of a cryptic splice site (12).
The effects of exonic point mutations are less well understood.
Until recently, it was normally assumed that nonsense muta-
tions produce truncated protein isoforms or in some cases
target the mRNA for destruction, whereas missense mutations
were thought to identify amino acids that are important for
protein structure or function. Translationally silent mutations
were normally classiﬁed as polymorphisms and considered
neutral. The generality of these assumptions is now being
challenged, in part through the analysis of the mRNAs pro-
duced from mutant alleles, and this analysis is leading to the
re-classiﬁcation of a number of exonic mutations and to the
realization that an even higher proportion of mutations affect
splicing (3). One possible explanation for the effects of such
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  Published online September 7, 2005mutations is that they interfere with the function of exonic
regulatory sequences. Indeed, recent data implicate ESE inac-
tivation by point mutations as a signiﬁcant cause of genetic
disease (13–26).
Several groups have employed functional systematic evolu-
tion of ligands by exponential enrichment (SELEX) for the
purpose of identifying sequences that can function as ESEs.
Functional SELEX, both in vivo (27) and in vitro (28–30), has
led to the discovery that a diverse array of both purine-rich and
non-purine-rich sequences can act as ESEs. A further reﬁne-
ment of functional SELEX allowed the identiﬁcation of
sequence motifs that can act as ESEs in response to speciﬁc
SR proteins (31,32). The motifs identiﬁed are short (6–8 nt),
degenerate and sometimes partially overlap. The frequencies
of the individual nucleotides at each position were used to
derive score matrices that can be used to predict the location
of SR protein-speciﬁc putative ESEs (31,32). The nucleotide-
frequency matrices are available in a web-based program
called ESEﬁnder (33). Previously, the matrices were used
to examine a limited set of exon sequences for the presence
of ESE motifs. Exonic high-score motifs were often found to
be clustered and also to be enriched in regions with known
natural enhancers (31,32). In addition, the motifs were found
to be present at a higher density within exons, compared with
introns. The predictive power of ESEﬁnder has been demon-
strated through the observation that a number of disease-
associated point mutations that result in exon skipping reduce
high-score motifs to below threshold values (13,14,17,
20,22,24–26). Conversely, a mutation that results in activation
of a cryptic 50 splice site due to increased SC35 binding to
an ESE, is consistent with the ESE scores predicted by
ESEﬁnder (34).
Ab initio computational approaches to identify ESE motifs
have recently been developed. RESCUE-ESE (35,36) identi-
ﬁed putative ESE motifs by comparing hexanucleotide fre-
quencies in constitutive exons with weak versus strong splice
sites. Sequences preferentially associated with weak splice
sites were clustered into several families and demonstrated
to possess enhancer activity when functionally tested. A simi-
lar approach compared octamer frequencies from internal
non-coding exons versus unspliced pseudo exons and the
50-untranslated regions (50-UTRs) of intronless genes, to
identify putative regulatory sequences involved in splicing
(37). This approach led to the discovery of both functional
enhancer and silencer sequences.
We have undertaken a large-scale analysis of SR-protein-
dependent ESE motif frequencies in the human genome using
ESEﬁnder. A thorough survey of ESE prevalence was war-
ranted, in light of the high percentage of mutations that cause
genetic diseases through aberrant splicing. In addition, a
genome-wide survey of ESE motifs in protein-coding genes
can give an indication of their importance in constitutive and
alternative splicing, and their overall contribution to exon
deﬁnition and splice-site selection.
MATERIALS AND METHODS
Database creation
The EnsMart search engine (38) was used to retrieve human
genomic sequence from Ensembl (version 24) (39). A set of
63218 constitutively spliced internal protein-coding exons
plus 100 nt each of ﬂanking upstream and downstream intronic
sequence, was derived from a total of 12216 genes. Constitu-
tive exons were deﬁned from genes having deﬁnitive annota-
tion in the NCBI Reference Sequence (RefSeq) collection,
whose transcripts demonstrated no evidence of alternative
splicing. Protein-coding exons were derived by BLAST
searching of exons with cDNA sequences, allowing the elim-
ination of non-coding and partially coding exons. We also
created a database of 2620 alternatively spliced (cassette)
exons from RefSeq genes with multiple transcripts, by map-
ping exons from these genes to their respective genomic coor-
dinates. For comparison with the alternative exons, we created
a set of 2880 constitutive exons selected to have a similar
length distribution (same mean and standard deviation of
exon lengths). A database of 20580 repeat-free intronic
pseudo exons was kindly provided by Dr Lawrence Chasin
(37). Sequence databases are available upon request.
Sequence analysis
ESE motif scores were calculated using the position weight
matrices available in ESEﬁnder version 2.0 (http://rulai.cshl.
edu/tools/ESE/) (33). The default threshold values from the
program were used. For the purposes of this study, we con-
sidered only above-threshold (high-score) ESE motifs as being
signiﬁcant. These thresholds were deﬁned previously as the
median of the highest score for each sequence in a set of
randomly chosen 20 nt sequences from the starting pool
used for the functional SELEX experiments (33). Note that
the motif scores for different SR proteins are not directly
comparable (33). Shufﬂed exonic and intronic sequences
were generated using the EMBOSS Shufﬂeseq program
(http://emboss.sourceforge.net/apps/shufﬂeseq.html).
Splice-site scores were calculated using score matrices
derived from the exon-ﬁnding program MZEF (40). The
matrices are based on position-dependent triplet-frequency
preferences for real versus pseudo splice sites in the window
( 15, +3) for 30 splice sites and ( 3, +8) for 50 splice sites.
Statistical analysis
Bootstrap sampling was used to determine the level of signiﬁ-
cance for the differences in average ESE motif frequencies
between exons and their ﬂanking introns, and exons and
pseudo exons. The mean ESEs/nt from random selections
of 10000 sequences from the exon, intron and pseudo exon
groups were sampled and compared 5000 times to derive
P-values. ESE motif frequency distributions were compared
by quantile–quantile analysis, and median values were com-
pared by the two-sample t-test. The signiﬁcance of the overlap
between motifs recognized by ESEﬁnder and RESCUE-ESE
or the putative ESEs of Zhang and Chasin was deﬁned by
Fisher’s exact test. Statistical tests with P-values <0.01
were deemed signiﬁcant.
RESULTS
ESE motif frequencies in constitutive exons
To date, most studies of ESE function have concentrated on
their role in alternative splicing, although functional ESEs are
5054 Nucleic Acids Research, 2005, Vol. 33, No. 16also present in constitutive exons (13,14,41,42). Important
questions remain unanswered, including the extent to which
ESEs participate in the process of constitutive splicing. A
large-scale analysis of ESE motif distribution in both exons
and introns would give some indication of their functional
relevance to splicing events of this nature.
We created a database of 63218 constitutively spliced inter-
nal protein-coding exons of lengths >100 nt from 12216
human genes. To standardize for differences in exon length,
we created composite 100 nt exon sequences consisting of
25 nt from each end plus 50 nt from the center. To ensure
that the exons were constitutively spliced, sequences were
collected from single-transcript genes. Exonic sequences
plus 100 nt each of ﬂanking upstream and downstream intronic
sequences were retrieved from Ensembl. For comparison, we
calculated ESE motif frequencies from a database of 20580
repeat-free intronic pseudo exons (37) also standardized to
100 nt, plus 100 nt each of 50- and 30-ﬂanking sequences.
ESEﬁnder scores sequences for the presence of motifs
matching the SELEX-derived consensus for four SR proteins:
SF2/ASF, SRp40, SRp55 and SC35 (33). We calculated
high-score ESE motif frequencies occurring at each position
in consecutive windows of 10 nt. For the purposes of this
study, all above-threshold values for a given motif were
considered to be equivalent.
The ESE motif frequency distributions (ESEs/10 nt) were
plotted separately for each SR protein (Figure 1). Points were
plotted at the central position of the high-score motif. ESE
motif frequencies were higher within exons than in the ﬂank-
ing intronic sequences for all four SR proteins. Sharp peaks
andtroughsat the exon/intron borders are aconsequence ofthe
conserved splice-site sequences. To avoid the contribution of
the splice-site consensus motifs, we calculated the mean ESE
motif frequencies (ESEs/nt) at the exact center of the exons
and each of the ﬂanking intronic regions (50 nt upstream of the
30 splice-site, and 50 nt downstream of the 50 splice-site)
(Table 1). A bootstrap sampling strategy of the mean ESE
motif frequencies revealed that the higher density of ESE
motifs in exons than in introns was statistically signiﬁcant
for all four SR proteins, and the P-values were all <0.001
for comparisons with both upstream and downstream ﬂanks.
ESE motif frequencies were approximately constant within
exons. By comparison, ESE motif frequencies in pseudo
exons were signiﬁcantly lower than in authentic exons for
Figure1.ESEmotiffrequencydistributionsinconstitutivecodingexonsandflankingintrons.ESEfinderwasusedtoanalyze63218constitutivecodingexons>100
nt in length for the presence of high-score ESE motifs. The green box represents a composite exon standardized to 100 nt, as described in the text. The thin lines
represent100nteachofflankingupstreamanddownstreamintronicsequence.ESEmotifscoresweremeasuredateachpositioninwindowsof10nt,andhigh-score
motifsplottedatthecentralpositionofthemotif.Exon/intronboundariesareindicatedbytheredverticaldashedlines.Thebluehorizontaldashedlinerepresentsthe
mean intronic ESE motif density. The consensus motif derived from functional SELEX is shown for each SR protein. Red letters indicate above-background
nucleotide frequencies.
Table 1. Mean ESE motif frequencies in constitutive exons, introns, and
pseudo exons (ESEs/nt)
SR
protein
Upstream
intron
Exon Downstream
intron
Upstream
flank
Pseudo
exon
Downstream
flank
SF2/ASF 0.0376 0.0496 0.0402 0.0387 0.0425 0.0431
SC35 0.0412 0.0448 0.0420 0.0422 0.0435 0.0424
SRp40 0.0398 0.0436 0.0405 0.0410 0.0426 0.0415
SRp55 0.0401 0.0442 0.0387 0.0432 0.0427 0.0426
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SF2/ASF, <0.01 for SC35, <0.006 for SRp40 and <0.02 for
SRp55). The frequencies of ESE motifs in intronic pseudo
exons were similar to the frequencies found in the other
intronic regions analyzed. As a control, we shufﬂed the exonic
and intronic sequences, maintaining the nucleotide composi-
tion, and scored the resulting sequences with ESEﬁnder. The
frequency of ESE motifs in the shufﬂed exonic sequences
decreased for all four of the SR proteins, whereas the frequen-
cies in shufﬂed intronic sequences were higher than in the real
intronic sequences (data not shown). This provides further
evidence for the functionality of the ESEﬁnder motifs when
present at exonic locations.
We observed a wide variation in the absolute numbers of
ESE motifs per exon when we analyzed the complete exons in
our constitutive exon database (Figure 2). The exons ranged in
size from 100 nt to  6 kb, and there was a modal frequency of
14 ESE motifs per exon. Interestingly, a small number of
exons (158) contained no ESE motifs, although it should be
emphasized that the current version of ESEﬁnder searches for
high-score motifs for only 4 of the  10 SR proteins.
Correlation of ESE motif frequencies with
splice-site strength
It has been postulated that one function of ESEs is the recruit-
ment of spliceosomal components to weak 50 or 30 splice sites
(43). Therefore, it is possible that exons with weak splice sites
will have elevated frequencies of ESEs. This property was one
of the criteria used to identify ESE motifs by RESCUE-ESE
(35). We chose to investigate this hypothesis in the context of
constitutive splicing, to eliminate as far as possible any com-
plications arising from mechanisms regulating alternative
splicing.
We calculated the 50 and 30 splice-site values for each exon
in our constitutive exon database. We then ranked the exons as
strong (top 15%) or weak (bottom 15%) for 50 and 30 splice
sites independently. ESEﬁnder was used to calculate high-
score ESE motifs from the four groups of exons. The number
of high-score ESE motifs was divided by exon length to give
ESEs/nt, and the frequency distributions were plotted as num-
ber of exons versus ESEs/nt. The ESE motif frequency dis-
tributions of the exons with strong and weak 30 splice sites
were compared, as were the distributions of the exons with
strong and weak 50 splice sites, by quantile–quantile analysis
(Supplementary Figure 1). This type of analysis determines if
two datasets come from populations with a common distribu-
tion. If the strong and the weak splice-site score exons have the
same distribution of ESE motifs, then the points will fall
approximately on the 45  reference line. Departure from the
45  reference line, either below or above, indicates higher
ESEs/nt in exons with strong or weak splice sites, respectively.
Differences in the ESE motif frequency distributions were
observed between exons with weak and strong splice sites,
for both 50 and 30 splice sites, for some of the SR proteins. A
summary of the data is shown in Table 2. The correlation of
ESE frequencies with splice-site strength reveals a compli-
cated relationship. For most of the comparisons, there are
no signiﬁcant differences between exons with strong versus
weaksplice sites.However,exonswithweak50 splicesitesand
exons with weak30 splice siteshave moreSRp55andSF2/ASF
motifs, respectively. In contrast, exons with strong 50 splice
sites have signiﬁcantly more SRp40 motifs than their weak
splice-site counterparts, and exons with strong 30 splice sites
have signiﬁcantly more SC35 and SRp40 motifs.
We further classiﬁed our constitutive exon dataset into
strong exons possessing both strong 50 and 30 splice sites
(top 15%), or weak exons possessing both weak 50 and 30
splice sites (bottom 15%). Quantile–quantile analysis
(Figure 3) of the ESE motif frequency distributions of these
two groups of exons revealed signiﬁcant differences in ESE
motif prevalence for three of the SR proteins: exons with
strong splice sites have more SC35 and SRp40 motifs,whereas
exons with weak splice sites have more SRp55 motifs
(Table 3). Therefore, there does not appear to be a simple
correlation between ESE motif frequencies and splice-site
strengths. When we combined the output of all four matrices
for the exondatasetsinTables 2 and3,the differencesbetween
strong and weak exons were averaged out (data not shown).
Our observations with the individual matrices suggest a poten-
tial role for a subset of the motifs and corresponding SR pro-
teins in the recognition of exons associated with weak splice
sites.
Comparison of ESE motif frequencies in constitutive
versus alternatively spliced exons
Alternative splicing events have previously been documented
to be associated with weak splice sites (44), traditionally on a
single transcript basis. Such a correlation is limited by the lack
of large-scale analyses. One recent report analyzed relatively
large datasets of both 50 and 30 splice site scores from con-
stitutive and alternative exons from a number of different
species, and found consistently higher scores for the constitu-
tive exons (45). However, the link between splice-site score
and alternative splicing remains unclear, and may not reﬂect a
Figure 2. Frequency distribution of ESE motifs in constitutive exons. ESE-
finderwas usedto score63218internalprotein-codingexons(>100nt) forthe
presence of high-score ESE motifs for SF2/ASF, SRp40, SRp55 and SC35.
Table 2. MeanESE motif frequencies in exons withstrong or weak splicesites
(ESEs/nt)
SR protein Strong 50 Weak 50 Strong 30 Weak 30
SF2/ASF 0.0435 0.0434 0.0400 0.0425
SC35 0.0417 0.0424 0.0427 0.0398
SRp40 0.0444 0.0427 0.0430 0.0415
SRp55 0.0241 0.0258 0.0240 0.0244
Frequencies in boldface are significantly higher than in the other exon set in a
pairwise comparison (strong versus weak) (two-sample t-test, P < 0.01)
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score and ESE motif frequencies in constitutive exons led us to
investigate the corresponding frequencies in alternative exons,
and their correlation with alternative splicing events. There are
several forms of alternative splicing[reviewed in(46)],andfor
simplicity we chose to investigate the most common one,
namely exon skipping/inclusion.
We created a database of 2620 skipped internal protein-
coding exons from RefSeq genes with multiple transcripts,
and scored them with ESEﬁnder. High-score ESE motifs
were divided by exon length to give ESEs/nt. This analysis
was repeated on a set of 2880 constitutive exons selected to
have a similar length distribution (same mean and standard
deviation of exon lengths). ESE motif frequency distributions
were derived and compared by quantile–quantile analysis
(Figure 4). Departure from the 45  reference line, either
below or above, indicates higher ESEs/nt in constitutive or
skipped exons, respectively. Scoring for all four SR proteins
combined revealed that ESE motif frequencies were signiﬁ-
cantly lower in skipped compared with constitutive exons,
with median values of 0.1466 and 0.1605 ESEs/nt, respec-
tively (two-sample t-test, P < 0.00001). The same result
was obtained when the exons were scored for individual SR
proteins. For example, skipped and constitutive exons scored
for SF2/ASF motifs had median values of 0.0384 and 0.0421
ESEs/nt, respectively (P < 0.0001).
The observation that skipped exons had signiﬁcantly fewer
ESE motifs than constitutive exons led us to examine the ESE
motif frequency distribution in the ﬂanking intronic regions of
skipped exons. We used ESEﬁnder to score 100 nt each of
Table3.MeanESEmotiffrequenciesinexonswithbothstrong50 and30 splice
sites and exons with both weak 50 and 30 splice sites (ESEs/nt)
SR protein Strong Weak
SF2/ASF 0.0429 0.0421
SC35 0.0440 0.0404
SRp40 0.0447 0.0416
SRp55 0.0238 0.0252
Frequencies in boldface are significantly higher than in the other exon set in a
pairwise comparison (strong versus weak) (two-sample t-test, P < 0.01).
Figure 3. Correlation ofESEmotiffrequencieswithsplice-site strength.Constitutiveexonswereclassifiedasweak,ifboththeir30 and 50 splice-sitescoreswerein
thebottom15%,orstrong,ifboththeir30 and50 splice-sitescoreswereinthetop15%.ESEmotiffrequencydistributionsfromthetwoexongroupswerecomparedby
quantile–quantile analysis.
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ESE motif frequencies (ESEs/nt) at the exact center of the
skipped exons and each of their ﬂanking introns (50 nt
upstream of the 30 splice-site, and 50 nt downstream of the
50 splice-site) were calculated (Table 4). Bootstrap resampling
of the mean frequencies demonstrated that only the SF2/ASF
motifs were signiﬁcantly higher in the skipped exons com-
pared with their ﬂanking introns (P < 0.001 for comparison
with upstream intron, P < 0.003 for comparison with down-
stream intron).
Calculation of the splice-site scores using position weight
matrices (40) revealed that the skipped exons had signiﬁcantly
weaker splice sites than the constitutively spliced exons.
The mean values with standard deviations were 84.2 ± 2.25
and 83.7 ± 2.7 for constitutive and skipped 30 splice sites,
respectively, and 46.93 ± 1.7 and 46.67 ± 2.09 for constitu-
tive and skipped 50 splice sites, respectively. These values
were signiﬁcantly different (all P-values <0.01) when ana-
lyzed by both parametric (one sample t-test) and non-
parametric (Wilcoxon rank test) statistical methods. It should
be noted that although the mean splice-site scores are signiﬁ-
cantly different, the distributions of splice-site scores for both
exon types are very similar (Figure 5), and that splice-site
scores alone are insufﬁcient to identify an exon as one that
is alternatively spliced.
ESE motif recognition by ESEfinder and ab initio
ESE-prediction methods
Two recent reports employed ab initio computational methods
to predict sequences that have ESE activity. RESCUE-ESE,
developed by the Burge laboratory (35), identiﬁed 238
hexamers preferentially associated with constitutive exons
with weak splice sites, whereas the methodology of Zhang
and Chasin (37) identiﬁed octamers overrepresented in
Figure 4. ESEmotiffrequenciesin constitutive versusalternativeexons.ESE-
finder was used to calculate ESE motif frequencies in 2620 skipped exons and
2880 constitutive exons of comparable length. ESE motif frequency distribu-
tions (ESEs/nt) were compared by quantile–quantile analysis for all four SR
proteins together (A), and for SF2/ASF alone (B).
Table 4. Mean ESE motif frequencies in skipped exons and their flanking
introns (ESEs/nt)
SR protein Upstream intron Exon Downstream intron
SF2/ASF 0.0387 0.0418 0.0403
SC35 0.0399 0.0402 0.0406
SRp40 0.0402 0.0398 0.0395
SRp55 0.0407 0.0409 0.0404
Figure 5. Splice-site score distributions of constitutively spliced and skipped
exons. Splice-site scores of 2620 skipped exons (dotted lines) and 2880 con-
stitutive exons (solid lines) were calculated and their frequency distributions
plotted separately for 30 (A) and 50 (B) splice-site scores.
5058 Nucleic Acids Research, 2005, Vol. 33, No. 16non-protein-coding exons compared with the 50-UTR of
intronless genes and pseudo exons. Both groups tested a num-
ber of candidate motifs and demonstrated enhancer function in
transfected cells. Although these two methods and ESEﬁnder
differ substantially, there may be some overlap in the
sequences they recognize as putative ESEs.
The functional SELEX-derived consensus motifs are a
hexamer for SRp55, heptamers for SF2/ASF and SRp40,
and an octamer for SC35 (33). Because the sequences iden-
tiﬁed by RESCUE-ESE are hexamers, we expanded each
RESCUE-ESE motif by the addition of either 1 (for SF2/
ASF and SRp40) or 2 (for SC35) nt, and scored the resulting
sequences with ESEﬁnder. As a control, we calculated the
number of all possible ESEﬁnder high-score motifs for each
SRprotein.Ofall16384heptamers,678(4.1%)arehigh-score
SF2/ASF motifs; 669 (4.1%) of all heptamers are high-score
SRp40 motifs; 2599 (4.0%) of all 65536 octamers are high-
score SC35 motifs; and 133 (3.2%) of all 4096 hexamers are
high-score SRp55 motifs. Using these percentages, we then
calculated the expected number of ESEﬁnder high-score
motifs from a complete random sample of allpossible oligonu-
cleotide sequences equal in length to the test set of
RESCUE-ESE sequences. For example, for SF2/ASF and
SRp40 (heptamer consensus motifs), the addition of 1 nt at
either the beginning or the end of the RESCUE-ESE hexamers
results in (4 · 238) · 2 ¼ 1904 sequences. We then calcu-
lated the expected number of ESEﬁnder high-score motifs
from 1904 random heptamers. The results of the comparison
(Table 5) indicate that the sequences recognized as ESE motifs
by RESCUE-ESE and ESEﬁnder do not overlap beyond what
is expected by chance.
A similar strategy was employed to investigate the extent of
overlap between the sequences recognized by ESEﬁnder and
the 2069 putative ESEs (PESEs) identiﬁed by Zhang and
Chasin (37). The PESEs were downloaded (http://www.
columbia.edu/cu/biology/faculty/chasin/xz3/octamers.txt)and
high-score ESE motifs calculated with ESEﬁnder. As a con-
trol, we calculated the expected number of high-score
ESEﬁnder motifs from a random sample of all possible
oligonucleotide sequences equal in length to the test set of
sequences. For example, there are two possible heptamers
contained within any one octamer; therefore, for SF2/ASF
and SRp40, we calculated the expected number of high-
score ESEﬁnder motifs from 2 · 2069 ¼ 4138 random
heptamers. The results for SC35, SRp40 and SRp55
(Table 6) reveal that high-score ESE motifs for these three
proteins are not enriched within the PESE set. However, there
are signiﬁcantly more SF2/ASF motifs (Table 6) than would
be expected by chance (P < 0.00001, Fisher’s exact test),
supporting the conclusion that there is some overlap between
the sequences identiﬁed as ESE motifs by these two very
different methods.
DISCUSSION
The importance of cis-regulatory sequences for accurate
splice-site recognition and exon deﬁnition is well documented.
However, most experimental studies to date have focused on
the regulation of single splicing events. A more global under-
standing of pre-mRNA splicing requires some knowledge of
the distribution of both splicing enhancers and silencers. Using
ESEﬁnder (33), we have undertaken a large-scale genomic
analysis in an attempt to uncover relationships between
ESE motif frequencies and splicing regulation. Many of the
experimental studies of ESE function have involved examina-
tion of their role inthe regulationof alternative splicing, and as
such little is known about their functional relevance to the
process of constitutive splicing. Our studies implicate ESE
participation in the regulation of both constitutive and alter-
native splicing.
Previously, the SR protein-speciﬁc matrices utilized by
ESEﬁnder were used to search a limited set of genomic
sequences for ESE motifs, which were found to occur more
frequently in exons versus introns (31,32,47). We have greatly
expanded these initial observations, and demonstrated a sig-
niﬁcant enrichment for ESE motifs in >60000 internal con-
stitutive protein-coding human exons. The motifs identiﬁed by
the RESCUE-ESE technique (35) and the PESEs of Zhang and
Chasin (37) also occur more frequently in exons versus
introns. ESEﬁnder motif frequencies within exons were
approximately constant, supporting the hypothesis that
ESEs function to activate splicing from varying distances
from the splice sites, an observation also made for the exonic
distribution of PESEs (37). In addition, constant ESE motif
frequencies alongexons may beaconsequence ofthe ability of
single enhancer motifs to inﬂuence recognition of both 30 and
50 splice sites (43,48,49). The functional SELEX experiments
used to derive the ESEﬁnder matrices were dependent upon
the ability of sequences to enhance splicing of a 30 terminal
exon (31,32). However, numerous studies have implicated
ESE motifs identiﬁed by ESEﬁnder in the splicing of internal
exons (13–17,20–26,34) and our new data support the conclu-
sion that these ESE motifs play a role in the splicing of internal
exons, in addition to terminal exons.
ESE motiffrequencies for threeofthe four SR proteins were
signiﬁcantlyhigherinexonsversuspseudoexons, supportinga
role for ESEs in exon deﬁnition, and consistent with previous
studies of genomic ESE motif distributions (37,47). Zhang and
Chasin (37) found fewer PESEs in the same set of pseudo
exons that we analyzed with ESEﬁnder, but identiﬁcation
Table 5. Comparison of ESE motif recognition by ESEfinder and
RESCUE-ESE
SR
protein
Number of
sequences
ESEfinder
high scores
Expected number
of high scores
SF2/ASF 1904 79 79
SC35 11424 179 453
SRp40 1904 64 78
SRp55 238 4 8
Total 15470 326 618
Table 6. Comparison of ESE motif recognition by ESEfinder and the putative
ESEs of Zhang and Chasin
SR
protein
Number of
sequences
ESEfinder
high scores
Expected number
of high scores
SF2/ASF 4138 263 171
SC35 2069 80 82
SRp40 4138 166 169
SRp55 6207 185 202
Total 16552 694 624
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tion in exons versus pseudo exons. Therefore, the observation
that the PESE motifs were more frequent in a second test set of
exons versus pseudo exons was a logical expectation (37). The
functional SELEX experiments used to derive the ESEﬁnder
motifs imposed no such a priori criteria; therefore, the fact that
these motifs are present at signiﬁcantly higher frequencies in
exons versus pseudo exons supports the conclusion that they
are involved in exon deﬁnition. In addition, there is evidence
supporting a role for silencers in the suppression of pseudo
exon splicing: a subset of pseudo exons with a relatively high
frequency of ESEﬁnder motifs was found to have increased
frequencies of elements capable of silencing splicing (47); and
Zhang and Chasin (37) also observed overrepresentation of
putative exonic splicing silencers in pseudo exons.
Experimental evidence demonstrated a role for ESEs in
constitutive splicing (13,14,41,42), a function supported by
our bioinformatic analysis. One ascribed function of ESEs
is facilitating the recognition of suboptimal splice sites.
Indeed, improving weak 30 splice-site polypyrimidine tracts
negates the enhancer requirement for a number of substrates
(50,51). However, there is no evidence that all exons with
weak splice sites have an increased dependence upon ESEs.
Our comparison of ESE motif frequencies in constitutive
exons with weak and strong splice sites implicates ESE
involvement in splice-site recognition of all exons. We
observed signiﬁcant differences in some ESE motif frequen-
cies when constitutive exons with strong and weak 30 or 50
splice sites were compared independently, or when exons with
both strong 30 and 50 splice sites were compared with their
counterparts with weak sites. However, there was not a simple
relationship between splice-site score and ESE motif fre-
quency, as in some instances exons with strong splice sites
were found to contain more ESE motifs. In addition, when we
repeated this analysis using Zhang and Chasin’s PESEs, we
observed no difference in the frequency of PESEs in exons
with weak splice sites compared with those with strong splice
sites (data not shown). It remains possible that weak splice
sites tend to be associated with stronger ESEs, rather than with
an increased number of ESEs, although it is known that mul-
tiple ESEs in the same exon act additively (52). This hypothe-
sis remains to be tested, and will require a more quantitative
version of ESEﬁnder.
A recent survey revealed an increase in the number of ESE
motifs identiﬁed by RESCUE-ESE in the vicinity of the splice
sites of constitutive exons (53). We only observed this trend
with SF2/ASF and SRp55 motifs in exons with weak 30 and 50
splice sites, respectively. As described above, ESE motifs for
some of the SR proteins are actually higher in exons with
strong splice sites. These differences in ESE motif distribu-
tions may be a consequence of the very different methods used
in their identiﬁcation. The motifs identiﬁed as putative
enhancers by RESCUE-ESE were constrained by the require-
ment to be enriched in constitutive exons with weak splice
sites, whereas the sequences identiﬁed by functional SELEX
were selected by their ability to activate exon inclusion in the
presence of a particular SR protein. It is possible that
RESCUE-ESE identiﬁed a set of enhancer sequences involved
in the recognition of a restricted set of exons, and that
ESEﬁnder recognizes enhancers involved in a more general
aspect of exon deﬁnition.
Alternative splicing serves to greatly expand the proteome,
with one recent report estimating that up to 74% of multiexon
human genes are alternatively spliced (54). ESEs, and the SR
proteins that bind them, have well deﬁned roles in regulating
the process of alternative splicing [reviewed in (1,4,5,44,55)].
A commonly held assumption states that exons that undergo
alternative splicing have weaker splice sites, by comparison
with those that are constitutively spliced. Our previous ana-
lysis of a limited set of alternatively spliced exons supported
this assumption (56). In addition, a recent report found sig-
niﬁcantly highersplice-site scores for constitutive versus alter-
native exons in ﬁve species, including humans (45). We
derived large datasets of constitutive and alternatively spliced
(included or skipped) protein-coding human exons, and again
demonstrated that alternatively spliced exons as a set have
signiﬁcantly weaker splice-site scores. However, the splice-
site score distributions are surprisingly similar and largely
overlapping, such that the splice-site scores alone are not
sufﬁcient to deﬁne a given exon as constitutive or alternative.
Intriguingly, we found that skipped exons have signiﬁcantly
fewer ESE motifs than constitutively spliced exons. In addi-
tion, skipped exons, unlike those that are constitutively
spliced, do not have increased ESE motif frequencies in com-
parison with their ﬂanking intronic regions, except for one of
the four SR proteins tested, SF2/ASF. Zhang and Chasin (37)
likewise reported ﬁnding fewer PESEs in alternative exons
compared with constitutive exons, and a comparable number
or slightly fewer RESCUE-ESE motifs were observed in
skipped exons (35). One can speculate that fewer ESEs per
exon may result in less efﬁcient exon deﬁnition, and subse-
quently lead to exon skipping. However, this remains a
hypothesis that will require appropriate experimental valida-
tion. Two recent publications (57,58) reported signiﬁcant con-
servation of the ﬂanking intronic regions of alternatively
spliced exons, perhaps implying a function for intronic motifs
in the control of alternative exon deﬁnition.
ESE motif identiﬁcation by functional SELEX, and the
computational methods of RESCUE-ESE or Zhang and
Chasin’s octamer analysis rely upon different methodologies.
However, the motifs identiﬁed share some commonalities,
namely overrepresentation in exons versus introns, and in
constitutive versus alternatively skipped exons. Interestingly,
our analysis revealed that the ESE motifs recognized by
ESEﬁnder and RESCUE-ESE do not signiﬁcantly overlap.
Nevertheless, experimental data proved the ability of both
methods to deﬁne functional enhancers (31,32,35), and as
described above, these differences may arise at least in part
from the constraint of association with weak splice sites inher-
ent in RESCUE-ESE. Over 80% of the RESCUE-ESE hex-
amers are found in the collection of PESEs (37). However, in
contrast to the analysis of RESCUE-ESE motif distribution
(53), there was no increase in PESE frequency near the splice
sites (37). This difference may be due to differences in the
exonic databases analyzed, or it may be a consequence of a
small subset of the RESCUE-ESE motifs accounting for the
observed increase near splice sites. Our scoring of Zhang and
Chasin’s PESEs with ESEﬁnder revealed no enrichment for
high-score SC35, SRp40 or SRp55 motifs. However, we did
ﬁnd an increase over the expected number of SF2/ASF motifs
within the PESE group, indicating some overlap between the
two methods. It should be noted that our analysis is limited to
5060 Nucleic Acids Research, 2005, Vol. 33, No. 16four SR proteins, and it is highly probable that both the set of
RESCUE-ESE hexamers and the PESE octamers contain
enhancer sequences recognized by other SR and non-SR
proteins, though these methods do not identify the factors
responsible for motif recognition.
ESEﬁnder scores sequences for the presence of putative
enhancers, and we emphasize that experimental validation
is required for deﬁnitive proof that any given motif is a
bona ﬁde ESE in its natural context. Other factors may
inﬂuence the ESE potential of any given motif. These include
sequence context, e.g. the presence of nearby silencers,
secondary structure effects and tissue-speciﬁc splicing factor
concentrations. Experimental efforts are underway to reﬁne
the original matrices. Future improvements will include
experimental reﬁnement of threshold values, and additional
SR protein-speciﬁc matrices.
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